Eurocor - Life Sciences Technologies Interventional Cardiology Devices Endovascular Therapies

Dediacted to Your heart.
Life Sciences Technology.
Coronary stent technologies and special cardiovascular and endovascluar devices made in Europe for the world.

Eurocors Valentines Trial published in EuroIntervention

Date: 2011/09/02

Eurocors Valentines Trial published in EuroIntervention

Valentines Trial in EuroIntervention electronically ahead of print

The Valentines Trial: results of the first one week worldwide multicentre enrolment trial, evaluating the real world usage of the second generation DIOR® paclitaxel drug-eluting balloon for in-stent restenosis treatment



Bonn, Germany, 02. September 2011 – Eurocor today announced the publication of the Valentines Trial in EuroIntervention electronically ahead of print. “We do hope that this database might have impact on patient treatment. All the honor goes to the 96 investigators from all 26 countries worldwide”, says Rembert Pogge von Strandmann, Clinical Director, Eurocor. The Valentines Trial database actually represents the largest group of ISR patients enrolled till date using a DEB to show effectiveness in treatment of in-stent restenosis (ISR). The DIOR® drug-eluting balloon (DEB) shows that it is safe and offers patients a treatment option for ISR without a second implant.

Download link for the publication on PCRonline:
http://www.pcronline.com/eurointervention/ahead_of_print/201108-04/

Eurocors Valentines Trial published in EuroIntervention

Eurocors Valentines Trial Studie publiziert in EuroIntervention